Genital Diseases, Female News

Genital Diseases, Female	Welcome, Profile Billing Logout

«1 2...27 28 29 30 313233 34 35 36 37...110 111 »

||||||||||  Votrient (pazopanib) / Novartis, BeiGene
Trial initiation date, Trial primary completion date:  Phase II Study of Pazopanib and Topotecan in Cervical Cancer (clinicaltrials.gov) -  Apr 21, 2016
P2, N=40, Not yet recruiting,  Sponsor: M.D. Anderson Cancer Center
Initiation date: Feb 2016 --> Aug 2016 | Trial primary completion date: Feb 2019 --> Aug 2019

||||||||||  letrozole / Generic mfg.
Trial withdrawal:  Femara (Letrozole) Versus Placebo for Patients With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (clinicaltrials.gov) -  Apr 20, 2016
P2, N=0, Withdrawn,  Sponsor: M.D. Anderson Cancer Center
Initiation date: Feb 2016 --> Aug 2016 | Trial primary completion date: Feb 2019 --> Aug 2019 Terminated --> Withdrawn

|||||||||| Trial primary completion date: DESTINy: Diafert® for Embryo Selection and Fertility Improvement (clinicaltrials.gov) - Apr 20, 2016
P3, N=60, Recruiting, Sponsor: Forest Laboratories
Terminated --> Withdrawn Trial primary completion date: Oct 2017 --> Apr 2017

|||||||||| Trial primary completion date: Diafert for Embryo Selection and Fertility Improvement (DESTINy) (clinicaltrials.gov) - Apr 20, 2016
P3, N=60, Recruiting, Sponsor: Forest Laboratories
Trial primary completion date: Oct 2017 --> Apr 2017 Trial primary completion date: Oct 2017 --> Apr 2017

|||||||||| Trial primary completion date: Screening Strategy for Asymptomatic Sexually Transmitted Infections (STI) in a Cohort of HIV Outpatients Men Who Have Sex With Men (DRIVER) (clinicaltrials.gov) - Apr 20, 2016
P=N/A, N=800, Recruiting, Sponsor: Hopital Foch
Trial primary completion date: Oct 2017 --> Apr 2017 Trial primary completion date: Dec 2015 --> Dec 2016

|||||||||| New trial: Zambia One Love Aim 3 Trial (clinicaltrials.gov) - Apr 20, 2016
P=N/A, N=3600, Recruiting, Sponsor: Emory University

|||||||||| New trial: Effect of a Yoghurt Containing Four Probiotic Lactobacillus Strains on Bacterial Vaginosis (clinicaltrials.gov) - Apr 20, 2016
P=N/A, N=216, Recruiting, Sponsor: Clinical Research Center Kiel GmbH

|||||||||| New trial: Role of Chronic Endometritis in Postoperative Recurrence of Severe Intrauterine Adhesions (clinicaltrials.gov) - Apr 20, 2016
P=N/A, N=125, Completed, Sponsor: First Affiliated Hospital, Sun Yat-Sen University

||||||||||  metformin / Generic mfg., carboplatin / Generic mfg., paclitaxel / Generic mfg.
Trial primary completion date, Combination therapy, Metastases:  OVMET: Study of Metformin With Carboplatin/Paclitaxel Chemotherapy in Patients With Advanced Ovarian Cancer (clinicaltrials.gov) -  Apr 20, 2016
P1, N=20, Recruiting,  Sponsor: University Medical Center Groningen
Trial primary completion date: Dec 2015 --> Dec 2016 Trial primary completion date: Jan 2016 --> Nov 2016

|||||||||| Enrollment closed: AriesIDE#1: ARIES for Vasculogenic Erectile Dysfunction (clinicaltrials.gov) - Apr 20, 2016
P1, N=23, Active, not recruiting, Sponsor: Dornier MedTech Systems
Trial primary completion date: Jan 2016 --> Nov 2016 Recruiting --> Active, not recruiting

|||||||||| Trial completion: p16 and Ki-67 Stainings and Natural Killer (NK) Cells in CIN-II Management (clinicaltrials.gov) - Apr 20, 2016
P=N/A, N=100, Completed, Sponsor: Parc de Salut Mar
Recruiting --> Active, not recruiting Active, not recruiting --> Completed

||||||||||  topotecan / Generic mfg., carboplatin / Generic mfg., cyclophosphamide / Generic mfg.
Trial primary completion date:  Topotecan, High-Dose Cyclophosphamide, Carboplatin, and an Autologous Peripheral Blood Cell Transplant in Treating Patients With Recurrent Ovarian Cancer or Primary Peritoneal Cancer (clinicaltrials.gov) -  Apr 19, 2016
P1, N=48, Active, not recruiting,  Sponsor: Mayo Clinic
Active, not recruiting --> Completed Trial primary completion date: Dec 2015 --> Dec 2016

||||||||||  progesterone / Generic mfg.
Trial primary completion date:  The Role of Progesterone and PIF for Successful Implantation and On-going Pregnancy in Assisted Reproductive Technology (clinicaltrials.gov) -  Apr 19, 2016
P=N/A, N=900, Enrolling by invitation,  Sponsor: Regionshospitalet Viborg, Skive
Trial primary completion date: Dec 2015 --> Dec 2016 Trial primary completion date: May 2016 --> May 2017

|||||||||| Trial completion: Aspiration of Limited Number of Follicles to Prevent Severe Ovarian Hyperstimulation Syndrome (clinicaltrials.gov) - Apr 19, 2016
P=N/A, N=30, Completed, Sponsor: Ahmad Hussieny Salama
Trial primary completion date: May 2016 --> May 2017 Recruiting --> Completed

|||||||||| Trial primary completion date: Circadian Variation in Serum-progesterone Levels Following Controlled Ovarian Hyperstimulation. (clinicaltrials.gov) - Apr 19, 2016
P=N/A, N=10, Recruiting, Sponsor: Regionshospitalet Viborg, Skive
Recruiting --> Completed Trial primary completion date: Mar 2016 --> Jul 2016

|||||||||| New trial, HEOR, Metastases: Preoperative Ascites Drainage Versus Standard Care for Patients With Advanced Ovarian Cancer (clinicaltrials.gov) - Apr 19, 2016
P=N/A, N=100, Not yet recruiting, Sponsor: Gdynia Oncology Center

||||||||||  cisplatin / Generic mfg., cyclophosphamide / Generic mfg., paclitaxel / Generic mfg.
Trial primary completion date, Metastases:  A Multi-Institutional Phase II Study of Cyclophosphamide, Paclitaxel, Cisplatin With G-CSF for Patients With Newly Diagnosed Advanced Stage Ovarian Cancer (clinicaltrials.gov) -  Apr 18, 2016
P2, N=47, Completed,  Sponsor: National Cancer Institute (NCI)
Trial primary completion date: Mar 2016 --> Jul 2016 Trial primary completion date: Nov 2013 --> Oct 2007

||||||||||  Lenvima (lenvatinib) / Eisai, Merck (MSD)
Trial completion, Enrollment change, Metastases:  Study of Lenvatinib in Subjects With Advanced Endometrial Cancer and Disease Progression (clinicaltrials.gov) -  Apr 18, 2016
P2, N=133, Completed,  Sponsor: Eisai Inc.
Trial primary completion date: Nov 2013 --> Oct 2007 Active, not recruiting --> Completed | N=167 --> 133

|||||||||| Trial completion, Trial primary completion date: Genetic Etiology in Premature Ovarian Insufficiency (clinicaltrials.gov) - Apr 18, 2016
P=N/A, N=100, Completed, Sponsor: BEGUM AYDOGAN
Active, not recruiting --> Completed | N=167 --> 133 Recruiting --> Completed | Trial primary completion date: Nov 2015 --> Apr 2016

||||||||||  Nexplanon (etonogestrel implant) / Organon
New trial:  vMICROb: Long-Acting Progestin Contraception and the Vaginal Microbiome (clinicaltrials.gov) -  Apr 18, 2016
P=N/A, N=35, Recruiting,  Sponsor: Boston Medical Center

||||||||||  mycophenolate mofetil / Generic mfg.
New trial:  Uterine Transplant in Absolute Uterine Infertility (AUIF) (clinicaltrials.gov) -  Apr 18, 2016
P=N/A, N=10, Not yet recruiting,  Sponsor: Brigham and Women's Hospital

|||||||||| Enrollment open: FemCure: Transmission of Genital and Extra-genital Chlamydia Trachomatis Infections in Women (clinicaltrials.gov) - Apr 18, 2016
P=N/A, N=400, Recruiting, Sponsor: Maastricht University Medical Center
Recruiting --> Completed | Trial primary completion date: Nov 2015 --> Apr 2016 Not yet recruiting --> Recruiting

||||||||||  Solithera (solithromycin) / Melinta Therap, Fujifilm Holdings
Trial primary completion date:  Genitourinary and Pharyngeal Pharmacokinetics of Solithromycin (clinicaltrials.gov) -  Apr 18, 2016
P1, N=28, Recruiting,  Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Not yet recruiting --> Recruiting Trial primary completion date: Dec 2015 --> Sep 2016

||||||||||  Merional (menotropin) / IBSA Institute Biochemical SA, Choriomon (human choriomon gonadotropin (hCG)) / IBSA Institute Biochemical SA
New P4 trial:  AIPRICSI: Role of Aromatase Inhibitor to Enhance Ovulation in Poor Responder During Induction With Short Antagonist Protocol in Cases of ICSI (clinicaltrials.gov) -  Apr 18, 2016
P4, N=20, Not yet recruiting,  Sponsor: Minia University

|||||||||| Biomarker, Enrollment change, Trial primary completion date, IO biomarker: Standard Operating Procedures for Cervical (Pre)Cancer Biomarker Detection in First-void Urine (BM-SOP Study) (clinicaltrials.gov) - Apr 17, 2016
P=N/A, N=100, Recruiting, Sponsor: Universiteit Antwerpen
Trial primary completion date: Dec 2015 --> Sep 2016 N=50 --> 100 | Trial primary completion date: Aug 2016 --> Dec 2016

||||||||||  carboplatin / Generic mfg., paclitaxel / Generic mfg.
Trial completion, Metastases:  Combination Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer or Primary Peritoneal Cancer (clinicaltrials.gov) -  Apr 17, 2016
P3, N=3882, Completed,  Sponsor: Gynecologic Oncology Group
N=50 --> 100 | Trial primary completion date: Aug 2016 --> Dec 2016 Active, not recruiting --> Completed

|||||||||| Trial completion: Follow-up of Ovarian Function in Young Women Who Underwent Ovarian Cortex Cryopreservation (clinicaltrials.gov) - Apr 15, 2016
P=N/A, N=546, Completed, Sponsor: Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Active, not recruiting --> Completed Enrolling by invitation --> Completed

|||||||||| New trial, Preclinical: Antimullerian Hormone Versus Antral Follicle Count for Determination of Gonadotrophin Dosing in IVF (clinicaltrials.gov) - Apr 15, 2016
P=N/A, N=200, Not yet recruiting, Sponsor: The University of Hong Kong

|||||||||| New trial: INREG 1: Multi-point Intra-mucosal Injections of Cross-linked Hyaluronic Acid (DESIRIAL®) in the Vaginal Vestibule (clinicaltrials.gov) - Apr 15, 2016
P=N/A, N=20, Not yet recruiting, Sponsor: Centre Hospitalier Universitaire de Nīmes

||||||||||  letrozole / Generic mfg.
New P3 trial:  Dual FSH/HCG Trigger in Letrozole Stimulated Intrauterine Insemination Cycles in Women With Unexplained Infertility (clinicaltrials.gov) -  Apr 15, 2016
P3, N=108, Completed,  Sponsor: Benha University

||||||||||  paclitaxel / Generic mfg.
New P2 trial:  Role of Intraperitoneal Intraoperative Chemotherapy With Paclitaxel in the Surgical Treatment of Peritoneal Carcinomatosis From Ovarian Cancer. Hyperthermia Versus Normothermia (clinicaltrials.gov) -  Apr 15, 2016
P2, N=32, Active, not recruiting,  Sponsor: Maimónides Biomedical Research Institute of Córdoba

|||||||||| Trial completion, Enrollment change: Immunopathogenesis of Chlamydia (clinicaltrials.gov) - Apr 15, 2016
P=N/A, N=29, Completed, Sponsor: Arkansas Children's Hospital Research Institute
Enrolling by invitation --> Completed Enrolling by invitation --> Completed | N=300 --> 29

|||||||||| Enrollment change, Trial termination, Biopsy: EndoBx-IVF: Effect of Endometrial Biopsy on in Vitro Fertilization Pregnancy Rates - a Multicenter Study (clinicaltrials.gov) - Apr 14, 2016
P=N/A, N=52, Terminated, Sponsor: Jon Havelock
Enrolling by invitation --> Completed | N=300 --> 29 N=332 --> 52 | Recruiting --> Terminated; Suboptimal subject recruitment

|||||||||| Enrollment change: Chlamydia Trachomatis Persistence in the Female Gastrointestinal Tract (clinicaltrials.gov) - Apr 14, 2016
P=N/A, N=0, Withdrawn, Sponsor: Arkansas Children's Hospital Research Institute
N=332 --> 52 | Recruiting --> Terminated; Suboptimal subject recruitment N=300 --> 0

||||||||||  triptorelin / Generic mfg.
New trial, Preclinical:  Effect of Prolonged GnRh Agonists on Results of Intracytoplasmic Sperm Injection (ICSI ) in Endometrioma Patients (clinicaltrials.gov) -  Apr 14, 2016
P=N/A, N=60, Recruiting,  Sponsor: Kasr El Aini Hospital

||||||||||  PSMA-targeted docetaxel (BIND-014) / Pfizer
Enrollment change, Trial termination:  iNSITE2: A Study of BIND-014 in Patients With Urothelial Carcinoma, Cholangiocarcinoma, Cervical Cancer and Squamous Cell Carcinoma of the Head and Neck (clinicaltrials.gov) -  Apr 14, 2016
P2, N=73, Terminated,  Sponsor: BIND Therapeutics
N=300 --> 0 N=160 --> 73 | Recruiting --> Terminated

||||||||||  Young TIL / National Cancer Institute
Enrollment change, Trial suspension, Metastases:  Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Human Papillomavirus-Associated Cancers (clinicaltrials.gov) -  Apr 14, 2016
P2, N=27, Suspended,  Sponsor: National Cancer Institute (NCI)
N=160 --> 73 | Recruiting --> Terminated N=73 --> 27 | Recruiting --> Suspended

|||||||||| Trial completion, Trial primary completion date, Surgery: MISSION: Minimally Invasive Interval Debulking Surgery in Ovarian Neoplasm: a Feasibility Study (clinicaltrials.gov) - Apr 14, 2016
P2, N=30, Completed, Sponsor: Catholic University of the Sacred Heart
N=73 --> 27 | Recruiting --> Suspended Active, not recruiting --> Completed | Trial primary completion date: Aug 2015 --> Feb 2015

|||||||||| Trial completion, Enrollment change, Trial primary completion date: KCCP: The Kilimanjaro Cervical Screening Project (clinicaltrials.gov) - Apr 13, 2016
P=N/A, N=1072, Completed, Sponsor: Queen's University
Active, not recruiting --> Completed | Trial primary completion date: Aug 2015 --> Feb 2015 Recruiting --> Completed | N=300 --> 1072 | Trial primary completion date: Dec 2015 --> Sep 2015

|||||||||| Trial completion: Study of the Consumer Use of a New Home Test to Measure Sperm Concentration (clinicaltrials.gov) - Apr 13, 2016
P=N/A, N=239, Completed, Sponsor: Sandstone Diagnostics
Recruiting --> Completed | N=300 --> 1072 | Trial primary completion date: Dec 2015 --> Sep 2015 Recruiting --> Completed

||||||||||  estradiol valerate / Generic mfg., triptorelin / Generic mfg.
New P3 trial:  Cryopreserved-thawed Embryo Transfer With or Without Gonadotropin Releasing Hormone Agonist (clinicaltrials.gov) -  Apr 13, 2016
P3, N=310, Recruiting,  Sponsor: Cairo University

|||||||||| Enrollment change, Trial suspension, PD(L)-1 Biomarker, IO biomarker, Gene therapy: T Cell Receptor Immunotherapy Targeting HPV-16 E6 for HPV-Associated Cancers (clinicaltrials.gov) - Apr 12, 2016
P2, N=10, Suspended, Sponsor: National Cancer Institute (NCI)
Recruiting --> Completed N=61 --> 10 | Recruiting --> Suspended

||||||||||  medroxyprogesterone injection / Generic mfg.
Trial initiation date:  Medroxyprogesterone in Treating Patients With Endometrioid Adenocarcinoma of the Uterine Corpus (clinicaltrials.gov) -  Apr 11, 2016
P2, N=75, Completed,  Sponsor: Gynecologic Oncology Group
N=61 --> 10 | Recruiting --> Suspended Initiation date: Oct 2003 --> Apr 2004

||||||||||  letrozole / Generic mfg., clomifene citrate / Generic mfg.
Trial completion, Trial initiation date, Trial primary completion date:  Comparison Between Letrozole and Urinary Purified FSH in Women With Clomiphene Citrate Resistant Polycystic Ovarian Syndrome. (clinicaltrials.gov) -  Apr 11, 2016
P3, N=140, Completed,  Sponsor: Cairo University
Initiation date: Oct 2003 --> Apr 2004 Recruiting --> Completed | Initiation date: Nov 2014 --> May 2013 | Trial primary completion date: May 2016 --> Jan 2015

||||||||||  danvatirsen (AZD9150) / AstraZeneca, Flamingo Therapeutics
Enrollment change, Trial termination:  AZD9150, a STAT3 Antisense Oligonucleotide, in People With Malignant Ascites (clinicaltrials.gov) -  Apr 11, 2016
P2, N=1, Terminated,  Sponsor: National Cancer Institute (NCI)
Recruiting --> Completed | Initiation date: Nov 2014 --> May 2013 | Trial primary completion date: May 2016 --> Jan 2015 N=15 --> 1 | Recruiting --> Terminated; Study was closed because we could not find these types of patients.

||||||||||  triptorelin / Generic mfg.
New P3 trial:  Dual Ovarian Stimulation in the Same IVF/ICSI Cycles for Treatment of Poor Ovarian Responders (clinicaltrials.gov) -  Apr 11, 2016
P3, N=50, Recruiting,  Sponsor: Royan Institute

|||||||||| Trial primary completion date: DNA Analysis in Samples From Younger Patients With Germ Cell Tumors and Their Parents or Siblings (clinicaltrials.gov) - Apr 9, 2016
P=N/A, N=932, Recruiting, Sponsor: Children's Oncology Group
N=15 --> 1 | Recruiting --> Terminated; Study was closed because we could not find these types of patients. Trial primary completion date: Nov 2015 --> Aug 2016

|||||||||| Trial primary completion date, BRCA Biomarker: Standard Genetic Counseling With or Without a Decision Guide in Improving Communication Between Mothers Undergoing BRCA1/2 Testing and Their Minor-Age Children (clinicaltrials.gov) - Apr 9, 2016
P3, N=400, Recruiting, Sponsor: Georgetown University
Trial primary completion date: Nov 2015 --> Aug 2016 Trial primary completion date: Dec 2015 --> Dec 2016

||||||||||  medroxyprogesterone injection / Generic mfg.
Trial completion:  Medroxyprogesterone in Treating Patients With Endometrioid Adenocarcinoma of the Uterine Corpus (clinicaltrials.gov) -  Apr 9, 2016
P2, N=75, Completed,  Sponsor: Gynecologic Oncology Group
Trial primary completion date: Dec 2015 --> Dec 2016 Active, not recruiting --> Completed

|||||||||| Trial completion: STI/HIV Prevention Intervention for Adolescents in Singapore (clinicaltrials.gov) - Apr 8, 2016
P=N/A, N=688, Completed, Sponsor: National University, Singapore
Active, not recruiting --> Completed Active, not recruiting --> Completed



	Diseases Companies Products Productz Mechanisms of Action Sites